[{"address1": "Bay & Deveaux Streets", "address2": "2nd Floor", "city": "Nassau", "country": "Bahamas", "phone": "800 936 9669", "fax": "514 332 2227", "website": "https://nymox.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul  Averback DABP, M.D.", "age": 73, "title": "Founder, Chairman, CEO & President", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lin  Dodd", "title": "QA and Compliance Manager", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick A. Doody", "age": 61, "title": "VP, General Counsel & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 100000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.088, "open": 0.0725, "dayLow": 0.0725, "dayHigh": 0.0725, "regularMarketPreviousClose": 0.088, "regularMarketOpen": 0.0725, "regularMarketDayLow": 0.0725, "regularMarketDayHigh": 0.0725, "payoutRatio": 0.0, "beta": 9.989, "volume": 1000, "regularMarketVolume": 1000, "averageVolume": 24184, "averageVolume10days": 30651, "averageDailyVolume10Day": 30651, "bid": 0.075, "ask": 0.0947, "bidSize": 45899, "askSize": 12600, "marketCap": 6854160, "fiftyTwoWeekLow": 0.0011, "fiftyTwoWeekHigh": 0.2, "allTimeHigh": 13.625, "allTimeLow": 0.0001, "fiftyDayAverage": 0.0612376, "twoHundredDayAverage": 0.0876691, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 10066160, "profitMargins": 0.0, "floatShares": 51829741, "sharesOutstanding": 94540140, "sharesShort": 2033620, "sharesShortPriorMonth": 2078231, "sharesShortPreviousMonthDate": 1684108800, "dateShortInterest": 1686787200, "sharesPercentSharesOut": 0.0223, "heldPercentInsiders": 0.45176998, "heldPercentInstitutions": 0.00054000004, "shortRatio": 59.74, "shortPercentOfFloat": 0.0465, "impliedSharesOutstanding": 104320152, "bookValue": -0.072, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -4492000, "trailingEps": -0.05, "enterpriseToEbitda": -2.351, "52WeekChange": -0.3958333, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 0.0725, "recommendationKey": "none", "totalCash": 74000, "totalCashPerShare": 0.001, "ebitda": -4282000, "totalDebt": 3286000, "quickRatio": 0.014, "currentRatio": 0.088, "returnOnAssets": -4.17935, "freeCashflow": -1077125, "operatingCashflow": -2601000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NYMXF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchange": "OQB", "messageBoardId": "finmb_389645", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -17.613638, "regularMarketPrice": 0.0725, "corporateActions": [], "regularMarketTime": 1760054400, "shortName": "Nymox Pharmaceutical Corp.", "longName": "Nymox Pharmaceutical Corporation", "marketState": "CLOSED", "fiftyTwoWeekChangePercent": -39.583332, "earningsTimestampStart": 1751540340, "earningsTimestampEnd": 1751540340, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.05, "fiftyDayAverageChange": 0.011262398, "fiftyDayAverageChangePercent": 0.18391313, "twoHundredDayAverageChange": -0.015169099, "twoHundredDayAverageChangePercent": -0.17302676, "priceToBook": -1.0069444, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 880554600000, "regularMarketChange": -0.015500002, "regularMarketDayRange": "0.0725 - 0.0725", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 24184, "fiftyTwoWeekLowChange": 0.0714, "fiftyTwoWeekLowChangePercent": 64.909096, "fiftyTwoWeekRange": "0.0011 - 0.2", "fiftyTwoWeekHighChange": -0.1275, "fiftyTwoWeekHighChangePercent": -0.6375, "displayName": "Nymox Pharmaceutical", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]